Two Sigma Advisers’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-748,076
| Closed | -$49.6M | – | 638 |
|
|
2025
Q4 | $49.6M | Buy |
748,076
+361,800
| +94% | +$23.4M | 0.1% | 182 |
|
|
2025
Q3 | $26M | Buy |
386,276
+372,600
| +2,724% | +$29.5M | 0.05% | 268 |
|
|
2025
Q2 | $1.19M | Sell |
13,676
-585,400
| -98% | -$45.9M | ﹤0.01% | 1356 |
|
|
2025
Q1 | $40.9M | Sell |
599,076
-644,700
| -52% | -$52.6M | 0.09% | 214 |
|
|
2024
Q4 | $96.7M | Buy |
1,243,776
+100,300
| +9% | +$7.43M | 0.22% | 81 |
|
|
2024
Q3 | $76.7M | Buy |
1,143,476
+739,000
| +183% | +$60.7M | 0.18% | 112 |
|
|
2024
Q2 | $45.9M | Buy |
+404,476
| New | +$51.1M | 0.1% | 187 |
|
|
2023
Q4 | – | Sell |
-56,476
| Closed | -$5.27M | – | 2535 |
|
|
2023
Q3 | $5.27M | Sell |
56,476
-260,600
| -82% | -$29.4M | 0.01% | 705 |
|
|
2023
Q2 | $40.7M | Sell |
317,076
-184,500
| -37% | -$22.3M | 0.1% | 201 |
|
|
2023
Q1 | $58.3M | Buy |
501,576
+430,900
| +610% | +$48.2M | 0.15% | 140 |
|
|
2022
Q4 | $8M | Sell |
70,676
-184,700
| -72% | -$20.3M | 0.02% | 581 |
|
|
2022
Q3 | $20.6M | Sell |
255,376
-845,600
| -77% | -$71.6M | 0.06% | 315 |
|
|
2022
Q2 | $82.1M | Buy |
1,100,976
+75,100
| +7% | +$6.85M | 0.23% | 104 |
|
|
2022
Q1 | $131M | Sell |
1,025,876
-739,600
| -42% | -$80.9M | 0.35% | 67 |
|
|
2021
Q4 | $237M | Buy |
1,765,476
+1,742,800
| +7,686% | +$250M | 0.59% | 48 |
|
|
2021
Q3 | $3.1M | Buy |
+22,676
| New | +$2.86M | 0.01% | 1022 |
|
|
2021
Q2 | – | Sell |
-17,076
| Closed | -$1.53M | – | 2506 |
|
|
2021
Q1 | $1.53M | Buy |
+17,076
| New | +$1.6M | ﹤0.01% | 1407 |
|
|
2020
Q4 | – | Sell |
-524,276
| Closed | -$54M | – | 2438 |
|
|
2020
Q3 | $54M | Buy |
524,276
+1,200
| +0.2% | +$125K | 0.15% | 140 |
|
|
2020
Q2 | $53M | Buy |
523,076
+99,200
| +23% | +$8.87M | 0.16% | 142 |
|
|
2020
Q1 | $28.5M | Buy |
423,876
+264,000
| +165% | +$16.4M | 0.11% | 216 |
|
|
2019
Q4 | $8.74M | Buy |
+159,876
| New | +$7.58M | 0.02% | 635 |
|
|
2019
Q3 | – | Sell |
-1,676,456
| Closed | -$62.8M | – | 2260 |
|
|
2019
Q2 | $62.8M | Sell |
1,676,456
-531,200
| -24% | -$16.7M | 0.16% | 165 |
|
|
2019
Q1 | $65.7M | Sell |
2,207,656
-571,600
| -21% | -$20.1M | 0.17% | 162 |
|
|
2018
Q4 | $83.2M | Buy |
2,779,256
+2,604,800
| +1,493% | +$82.6M | 0.23% | 120 |
|
|
2018
Q3 | $6.24M | Buy |
+174,456
| New | +$5.41M | 0.02% | 743 |
|
|
2016
Q1 | – | Sell |
-12,720
| Closed | -$260K | – | 2054 |
|
|
2015
Q4 | $260K | Sell |
12,720
-228,864
| -95% | -$4.76M | ﹤0.01% | 1572 |
|
|
2015
Q3 | $5.19M | Buy |
+241,584
| New | +$5.39M | 0.03% | 463 |
|
|
2015
Q1 | – | Sell |
-50,056
| Closed | -$689K | – | 2024 |
|
|
2014
Q4 | $689K | Buy |
+50,056
| New | +$613K | 0.01% | 1394 |
|
|
2014
Q2 | – | Sell |
-67,256
| Closed | -$697K | – | 2497 |
|
|
2014
Q1 | $697K | Buy |
67,256
+4,800
| +8% | +$49.6K | 0.01% | 1366 |
|
|
2013
Q4 | $553K | Buy |
62,456
+24,400
| +64% | +$193K | 0.01% | 1533 |
|
|
2013
Q3 | $268K | Buy |
+38,056
| New | +$241K | ﹤0.01% | 1753 |
|
Other funds holding DXCM
VCM
VPM
Two Sigma Advisers's DXCM Position: Q1 2026 in Review
Two Sigma Advisers sold out of DexCom (DXCM) in Q1 2026, closing a stake of 748,076 shares — an estimated $49.6M sold.
Two Sigma Advisers first reported a position in DXCM in Q3 2013 and held it in 31 quarters. The position peaked at $237M in Q4 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Two Sigma Advisers reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 748,076 DexCom shares in Q1 2026, an estimated $49.6M.
- Two Sigma Advisers first reported a position in DexCom in Q3 2013 and held it in 31 quarters.
- Two Sigma Advisers's DexCom position peaked at $237M in Q4 2021.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.